[1] Wang XS,Zhuang QY,Weng XS,et al.Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients.Chin Med J (Engl).2013; 126(2): 290-295. [2] Gong LL,Fang LH, Wang HY, et al. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis. Steroids.2013;78(4):401-408. [3] Sun Z,Yang S,Ye S,et al.Aberrant CpG islands' hypermethylation of ABCB1 in mesenchymal stem cells of patients with steroid-associated osteonecrosis. J Rheumatol.2013;40(11):1913-1920. [4] Chernetsky S,Mont M,Laporte D,et al.Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin Orthop Relat Res.1999;368(368): 149-161. [5] Plenk HJ, Gstettner M, Grossschmidt K, et al. Magnetic resonance imaging and histology of repair in femoral head osteonecrosis. Clin Orthop Relat Res. 2001; 386(386): 42-53. [6] 曾平,何伟,韦标方.复方生脉成骨胶囊治疗塌陷前期非创伤性股骨头坏死的临床研究[J]. 中国中医骨伤科杂志, 2010,18(2):14-17. [7] Qin L,Zhang G,Sheng H,et al.Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone. 2008;39(4):863-871. [8] Ikemura S, Yamamoto T, Motomura G, et al.Cytochrome P4503A activity affects the gender difference in the development of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol.2014;95(2): 147-152. [9] Sheng H, Sheng CJ, Cheng XY, et al. Pathomorphological changes of bone marrow adipocytes in process of steroid-associated osteonecrosis. Int J Clin Exp Pathol. 2013; 6(6): 1046-1050. [10] 周正新.中药干预修复激素性股骨头坏死:基础实验与临床应用转化的距离?[J].中国组织工程研究,2015,19(29): 4726-4730. [11] 周正新.袁浩教授论治股骨头缺血性坏死的学术特点[J].中医正骨,2003, 15(6): 56. [12] 陈卫衡.股骨头坏死“痰瘀同治”的理论基础[J].江苏中医药, 2008, 40(5): 3-4. [13] 孙文山.股骨头缺血性坏死治疗常用药及组方规律探析[J].中医正骨, 2003, 15(4): 59-60. [14] 易浪,方斌,陈鹏,等.桃红四物汤对巨噬细胞TGF-β1和TNF-α mRNA转录的影响[J].中国实验方剂学杂志,2013, 19(2):178-182. [15] 陈鹏,方斌,易浪,等.桃红四物汤含药血清对巨噬细胞的影响[J]. 中国药理学通报, 2013, 29(4):582-584. [16] He W, Li K. Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head. Acta Orthop. 2009; 80(3): 325-329. [17] Estabelle A, Qian L, Ming Q, et al. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK. J Cell Biochem. 2011;12(1): 89-97. [18] Franceca GB, Lorenz C, Bauer H, et al. The expression of osteoprotegerin and RANK ligand support of osteoclast for mation by stromal-osteoblast lingeage cells is developmentally regulated. Endocrinology. 2000;141(12): 4768-4776. [19] Crombrugghe BD, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 2001;13(6): 721-728. [20] Yoshikazu M, Kazuki O, Shigeyuki K, et al. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Biochem Biophys Res Commun.2007;362(2):368-373. [21] Whitlock PR, Hackett NR, Leopold PL, et al. Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs. Mol Ther. 2004; 9(1): 67-75. |